Real-time enrollment status for this chondral defect clinical trial
Current Status
Recruiting
Checked: July 24, 2026 at 10:07 AM UTC
| NCT Number | NCT06915233 |
| Recruiting Status | Recruiting |
| Condition | Chondral Defect |
| Phase | PHASE3 |
| Target Enrollment | 309 participants |
| Active Locations | 7 sites in the US |
| Sponsor | Vericel Corporation |
| Last Updated on CT.gov | July 23, 2026 (Yesterday) |
As of July 24, 2026: Clinical trial NCT06915233 is currently recruiting participants. This phase3 study for chondral defect is actively seeking new participants at 7 locations across the United States. The study is sponsored by Vericel Corporation. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06915233 is actively recruiting participants as of July 24, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 7 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06915233 was last updated Yesterday (July 23, 2026). HelloStudys verifies this status automatically.